TERN - Terns Pharmaceuticals, Inc.

QQQ $ 607.31 $ 0.00 (0 %)

DIA $ 471.11 $ 0.00 (0 %)

SPY $ 670.34 $ 0.00 (0 %)

TLT $ 89.06 $ 0.00 (0 %)

GLD $ 374.11 $ 0.00 (0 %)

Previous Close

$ 22.56

Open

$ 20.42

Bid

$ 22.90 x 5,000

Ask

$ 23.10 x 2

Day's Range

-- - --

52 Week Range

$ 1.87 - $ 23.31

Volume

3,930,186

Average Volume

Market Cap

2.03B

Beta (5Y Monthly)

$ 0.95

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-10-2025	09-30-2025	10-Q
2	08-05-2025	06-30-2025	10-Q
3	05-08-2025	03-31-2025	10-Q
4	03-20-2025	12-31-2024	10-K
5	11-12-2024	09-30-2024	10-Q
6	08-05-2024	06-30-2024	10-Q
7	05-13-2024	03-31-2024	10-Q
8	03-14-2024	12-31-2023	10-K
9	11-14-2023	09-30-2023	10-Q
10	08-08-2023	06-30-2023	10-Q
11	05-15-2023	03-31-2023	10-Q
12	03-27-2023	12-31-2022	10-K
13	11-09-2022	09-30-2022	10-Q
14	08-08-2022	06-30-2022	10-Q
15	05-16-2022	03-31-2022	10-Q
16	03-07-2022	12-31-2021	10-K
17	11-15-2021	09-30-2021	10-Q
18	08-16-2021	06-30-2021	10-Q
19	05-14-2021	03-31-2021	10-Q
20	03-30-2021	12-31-2020	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Mizuho Maintains Outperform on Terns Pharm...
11/13/2025 13:30:48

Mizuho analyst Graig Suvannavejh maintains Terns Pharma (NASDAQ:TERN) with a Outperform and raises the price target from $32...

Barclays Maintains Overweight on Terns Pha...
11/11/2025 15:34:23

Barclays analyst Etzer Darout maintains Terns Pharma (NASDAQ:TERN) with a Overweight and raises the price target from $27 to...

Terns Pharma Q3 EPS $(0.27) Beats $(0.30) ...
11/10/2025 21:43:24

Terns Pharma (NASDAQ:TERN) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.30) ...

henry-schein-sanmina-wingstop-waters-and-other-big-stocks-moving-higher-on-tuesday

Henry Schein, Sanmina, Wingstop, Waters An...
11/04/2025 17:37:39

12 Health Care Stocks Moving In Tuesday's ...
11/04/2025 17:06:03

Truist Securities Reiterates Buy on Terns ...
11/04/2025 16:06:14

Truist Securities analyst Srikripa Devarakonda reiterates Terns Pharma (NASDAQ:TERN) with a Buy and raises the price target ...

BMO Capital Maintains Outperform on Terns ...
11/04/2025 14:19:40

BMO Capital analyst Etzer Darout maintains Terns Pharma (NASDAQ:TERN) with a Outperform and raises the price target from $15...

Barclays Maintains Overweight on Terns Pha...
11/04/2025 14:05:30

Barclays analyst Etzer Darout maintains Terns Pharma (NASDAQ:TERN) with a Overweight and raises the price target from $14 to...

HC Wainwright & Co. Upgrades Terns Pharma ...
11/04/2025 12:17:20

HC Wainwright & Co. analyst Andres Y. Maldonado upgrades Terns Pharma (NASDAQ:TERN) from Neutral to Buy and announces $2...

William Blair Upgrades Terns Pharma to Out...
11/03/2025 21:24:34

William Blair analyst Andy Hsieh upgrades Terns Pharma (NASDAQ:TERN) from Market Perform to Outperform.

kenvue-idexx-laboratories-freshpet-and-other-big-stocks-moving-higher-on-monday

Kenvue, IDEXX Laboratories, Freshpet And O...
11/03/2025 19:13:22

terns-pharmaceuticals-leukemia-drug-seen-as-potential-disruptor-in-cml-treatment-landscape-analyst-upgrades

Terns Pharmaceuticals' Leukemia Drug Seen ...
11/03/2025 18:05:11

Terns Pharmaceuticals shares rise after TERN-701 shows a 75% response rate in the CML trial, and William Blair upgrades the sto...

12 Health Care Stocks Moving In Monday's I...
11/03/2025 17:05:47

Terns Pharmaceuticals Announces TERN-701 S...
11/03/2025 14:13:02

Unprecedented Phase 1 CML efficacy data with 64% MMR achievement by 24 weeks in a refractory patient populationEncouraging safe...

JMP Securities Maintains Market Outperform...
10/23/2025 13:14:27

JMP Securities analyst Silvan Tuerkcan maintains Terns Pharma (NASDAQ:TERN) with a Market Outperform and lowers the price ta...

why-is-terns-pharmaceuticals-stock-trading-lower-after-obesity-trial-data

Why Is Terns Pharmaceuticals Stock Trading...
10/22/2025 18:43:39

Terns Pharmaceuticals announces 12-week Phase 2 results for oral obesity drug TERN-601, showing up to 4.6% weight loss but repo...

Barclays Maintains Overweight on Terns Pha...
10/22/2025 16:27:13

Barclays analyst Etzer Darout maintains Terns Pharma (NASDAQ:TERN) with a Overweight and lowers the price target from $15 to...

netflix-posts-downbeat-earnings-joins-aveanna-healthcare-texas-instruments-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

Netflix Posts Downbeat Earnings, Joins Ave...
10/22/2025 12:16:12

why-intuitive-surgical-shares-are-trading-higher-by-around-16-here-are-20-stocks-moving-premarket

Why Intuitive Surgical Shares Are Trading ...
10/22/2025 09:55:35

12 Health Care Stocks Moving In Tuesday's ...
10/21/2025 21:06:33